Dexamethasone inhibits antitumor potential of activated macrophages by a receptor mediated action

The capacity to inhibit P815 mastocytoma growth was induced in macrophages elicited by trehalose dimycolate by a short in vitro treatment with 10 ng/ml LPS. Activation by LPS was associated with a 3 fold increase in the rate of glucose consumption by macrophages. Incubation of activated macrophages with the glucocorticoid dexamethasone (greater than or equal to 10(-8) M) for several hours (greater than or equal to 5 h) resulted in an inhibition of antitumoral activity and a decrease of glucose consumption. Hydrogen peroxide production is a property expressed by trehalose dimycolate-elicited macrophages independently of the presence of LPS. The capacity to release hydrogen peroxide upon triggering was not affected by a pretreatment of macrophages by dexamethasone. The antiglucocorticoid compound RU 38486, known to bind with a high affinity to glucocorticoid receptors without agonist effect, prevented the inhibitory actions of dexamethasone, indicating that these are receptor-mediated.